Hospira.comAbout HospiraNews & MediaIn the CommunitySearch :  
Home
Australia

Indications:

Adults: KYTRIL (tablets and injection) is indicated for use in:

  • The prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy.
  • The prevention of nausea and vomiting induced by radiotherapy.
  • KYTRIL injection is also indicated for the prevention and treatment of post-operative nausea and vomiting.
Children: KYTRIL injection is indicated for use in:
  • The prevention of nausea and vomiting induced by cytotoxic chemotherapy.

KYTRIL® is a registered trade mark of F. Hoffmann-La Roche AG

Consumer Medicine Information (PDF links):

Kytril for Injection
Kyrtil Tabs

For further information refer to your doctor

Kytril® (granisetron) is available in:

  • 1mg/1mL Injection Ampoule
  • 3mg/3mL Injection Ampoule
  • 2mg tablets (singles)
  • 2mg tablets

Kytril® is a potent antiemetic and highly selective antagonist of 5-hydroxytryptamine (5-HT)3 receptors.
This Web site and its information is intended for use by Australian residents only. Countries outside of Australia may have regulatory requirements, data requirements or medical practices that differ from Australia and, therefore, this information may be inappropriate for use outside of Australia. Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.